CAS: 20315-46-2 - 5'α(S)-sec-butyl-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione

Formula: C₃₂H₄₁N₅O₅

InChI: InChI=1S/C32H41N5O5/c1-6-18(4)27-29(39)36-12-8-11-25(36)32(41)37(27)30(40)31(42-32,17(2)3)34-28(38)20-13-22-21-9-7-10-23-26(21)19(15-33-23)14-24(22)35(5)16-20/h7,9-10,13,15,17-18,20,24-25,27,33,41H,6,8,11-12,14,16H2,1-5H3,(H,34,38)/t18-,20+,24+,25-,27-,31+,32-/m0/s1

InChI key: InChIKey=YYWXOXLDOMRDHW-SDMXVIBFSA-N

SMILES: O=C(NC1(OC2(O)N(C1=O)C(C(=O)N3CCCC32)C(C)CC)C(C)C)C4C=C5C=6C=CC=C7NC=C(C76)CC5N(C)C4

Synonyms:

• (5'beta)-5'-[(2S)-butan-2-yl]-12'-hydroxy-3',6',18-trioxo-2'-(propan-2-yl)ergotaman
• (5′α)-12′-Hydroxy-2′-(1-methylethyl)-5′-[(1S)-1-methylpropyl]ergotaman-3′,6′,18-trione
• 5'alpha(S)-sec-Butyl-12'-hydroxy-2'-isopropylergotaman-3',6',18-trione
• 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, ergotaman-3′,6′,18-trione deriv.
• Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-(1-methylethyl)-5′-(1-methylpropyl)-, [5′α(S)]-
• Ergotaman-3′,6′,18-trione, 12′-hydroxy-2′-(1-methylethyl)-5′-[(1S)-1-methylpropyl]-, (5′α)-
• Indolo[4,3-fg]quinoline, ergotaman-3′,6′,18-trione deriv.
• beta-Ergocryptine
• beta-Ergokryptine
• β-Ergocryptine
• β-Ergokryptine

β-Ergocryptine

CAS: 20315-46-2

• Formula: C₃₂H₄₁N₅O₅
• Molecular weight: 575.71

b-Ergocryptine

CAS: 20315-46-2

Ergocryptine is a drug that is used to treat Parkinson’s disease. It is an active …

• Purity: Min. 95%

Beta-Ergocryptine-d3

CAS: 20315-46-2

• Formula: C₃₂D₃H₃₈N₅O₅
• Color and Shape: Neat
• Molecular weight: 578.72

β-Ergocryptine

CAS: 20315-46-2

• Formula: C₃₂H₄₁N₅O₅
• Color and Shape: Off-White
• Molecular weight: 575.70